Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial. - Kang J; Park KW; Han JK; Hwang D; Yang HM; Park S; Ahn HS; Hwang KK; Kim BG; Jeong JO; Ahn JH; Rhew JY; et al. (Lancet (London, England), 2025)